Live feed17:15:27·1653dSECFilingvia QuantisnowSigilon Therapeutics, Inc. filed SEC Form 8-K: Costs Associated with Exit or Disposal Activities, Regulation FD Disclosure, Financial Statements and ExhibitsByQuantisnow·Wall Street's wire, on your screen.SGTX· Sigilon Therapeutics Inc.Health CareOriginal source
